Abstract:Jun Cao, 1, &ast Lin Hua, 2, &ast Liang Dong, 3 Zhouhuan Wu, 4 Guohui Xue 2 1 Department of Biochemistry and Molecular Biology, School of Medicine, Jiujiang University, Jiujiang, People's Republic of China; 2 Department of Clinical Laboratory, Jiujiang NO.1 People's Hospital, Jiujiang, People's Republic of China; 3 Department of Rheumatology, Jiujiang NO.1 People's Hospital, Jiujiang, People's Republic of China; 4 Department of Pharmacology, School of Medicine, Jiujiang University, Jiujiang, People's Republic of China &astThese authors contributed equally to this work Correspondence: Guohui Xue, Email Background: Inflammatory responses and metabolic abnormalities play essential roles in the pathophysiology of osteoarthritis (OA). Our study aimed to evaluate the association between monocyte-to-high density lipoprotein-cholesterol ratio (MHR) and OA and compared it with other systemic inflammatory markers. Methods: This study recruited 323 OA cases and age- and sex-matched 283 control participants during the same period. Demographic, clinical, and imaging data and laboratory indicators were obtained from participants' records. Systemic inflammatory markers were calculated for both cohorts. The diagnostic effectiveness of each index for distinguishing patients with OA was analyzed using receiver operating characteristic (ROC) curves. Spearman's method and ordered logistic regression were used to analyze the association between each indicator and Kellgren and Lawrence (KL) grade. Results: MHR was significantly higher (0.38± 0.18 vs 0.25± 0.07, p < 0.0001) in OA patients than healthy controls. MHR had the largest area under the ROC curve for predicting OA. Analysis of ordered logistic regression indicated that MHR was a risk factor for OA radiological severity. Spearman correlation analysis indicated that MHR significantly correlates with the KL grade. Moreover, MHR was significantly higher in early stage patients than in healthy controls. Conclusion: These results suggest that an elevated MHR could reflect knee OA severity and might be a useful marker for diagnosis and monitoring of OA. Keywords: osteoarthritis, disease severity, monocyte to high-density lipoprotein cholesterol ratio, inflammation, biomarker Osteoarthritis (OA) is the most prevalent joint disorder in older adults worldwide, with approximately 250 million patients, with knee OA being the predominant type. 1 In addition, as the global population ages, the incidence of OA increases yearly, with some studies predicting an increase of more than 40% by 2025. 2 Persistent degenerative changes in the articular cartilage can lead to cartilage sclerosis and bone fragmentation. In addition, patients with OA can present with increased inflammatory infiltration, vascularization and fibrosis of infrapatellar fat pad, as well as concurrent inflammation of synovial membrane and meniscal degeneration. 3–5 These pathological phenotypes can further affect joint homeostasis and promote and perpetuate joint damage. Hence, patients with advanced diseases often require joint replacement surgery, posing significant health and economic challenges to individuals and society. 6 Currently, the diagnosis and assessment of OA severity are based on clinical and imaging criteria. 7 However, these are usually ineffective in detecting OA until the patient is in an advanced stage. 8 Studies have revealed that certain cellular or molecular changes appear much earlier than obvious clinical signs. 9 Therefore, the search for OA biomarkers has become a focus in this field. 10 Unfortunately, clinically applicable biomarkers for diagnosing OA and assessing its severity are unavailable. 11 The underlying molecular mechanisms of OA are not fully understood; however, substantial evidence indicates that inflammatory and metabolic changes play essential roles in the pathophysiology of OA. 12 Certain cytokines and mediators produced by joint-infiltrating immune cells can accelerate articular cartilage degeneration, inflammation of synovial membrane, meniscal degeneration and inflammation and fibrosis of the infrapatellar fat pad. 13 Among these immune cells, Monocytes (MON) can migrate to tissues and secrete inflammatory cytokines, influencing the level of the inflammatory response. Additionally, their numerical and phenotypic changes can be markers reflecting the degree of inflammation. 14 In addition, plasma levels of high-density lipoprotein cholesterol (HDL-C) were significantly and negatively associated with OA risk. 15 Thus, the monocyte-to -Abstract Truncated-

YKL-40: a potential biomarker for osteoarthritis.

The role of YKL-40 in the pathogenesis of autoimmune diseases: a comprehensive review

IL-40 is up-regulated in the synovial fluid and cartilage of osteoarthritis patients and contributes to the alteration of chondrocytes phenotype in vitro

The Elevated Expression of IL-38 Serves As an Anti-Inflammatory Factor in Osteoarthritis and Its Protective Effect in Osteoarthritic Chondrocytes.

YKL-40 As a New Biomarker of Disease Activity in Takayasu Arteritis.

Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease.

Increased Circulating Levels of YKL-40 Protein in Children and Adolescents with Hemophilia: Correlation with the Degree of Hemophilic Arthropathy

YKL-40 Is Associated With Ultrasound-Determined Carotid Atherosclerotic Plaque Instability

Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT

The secretion of proinflammatory cytokines and chemokines in stimulated fibroblast-like synoviocytes of osteoarthritis

Yiqi Yangxue formula inhibits cartilage degeneration in knee osteoarthritis by regulating LncRNA-UFC1/miR-34a/MMP-13 axis

YKL-40 levels increase with declining ankle-brachial index and are associated with long-term cardiovascular mortality in peripheral arterial disease patients

Diagnostic biomarkers in knee osteoarthritis: Based on bioinformatics and experimental verification in vivo and in vitro

Serum Levels of the Bone Turnover Markers Dickkopf-1, Osteoprotegerin, and TNF-α in Knee Osteoarthritis Patients

A comprehensive analysis of biomarkers associated with synovitis and chondrocyte apoptosis in osteoarthritis

Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases

YKL-40 (chitinase-3-like protein 1) serum levels are associated with abdominal aortic calcification in hemodialysis patients

Biomarkers for hypertrophic chondrocyte differentiation are associated with spatial cellular organisation and suggest endochondral ossification-like processes in osteoarthritic cartilage: An exploratory study

Glycation marker glucosepane increases with the progression of osteoarthritis and correlates with morphological and functional changes of cartilage in vivo

The Value of the Monocyte to High-Density Lipoprotein Cholesterol Ratio in Assessing the Severity of Knee Osteoarthritis: A Retrospective Single Center Cohort Study

Identification of plasma and urinary inflammatory markers in severe knee osteoarthritis: Relations with synovial fluid markers